US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on May 13 for "Recombinant virus with diminished latency and methods of using same" (Maryland, Virginia Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,296,004, issued on May 13, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Recombinant virus with diminished latency and methods of using same" was invented by Jeffrey I. Cohen (Bethesda, Md.) and Lesley Pesnicak (Stafford, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides recombinant herpes virus with diminished latency. In embodiments, the recombinant herpes virus comprises a latency gene or transcript linked to an altered or heterologous promoter. The disclosure also provides compositions and methods for inducing immunity in animals using...